Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Equity Ratio (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Equity Ratio for 16 consecutive years, with 0.29 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 16.8% year-over-year to 0.29, compared with a TTM value of 0.29 through Dec 2025, up 16.8%, and an annual FY2025 reading of 0.29, up 16.8% over the prior year.
  • Equity Ratio was 0.29 for Q4 2025 at Amicus Therapeutics, up from 0.27 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.39 in Q3 2021 and bottomed at 0.15 in Q1 2023.
  • Average Equity Ratio over 5 years is 0.24, with a median of 0.24 recorded in 2024.
  • The sharpest move saw Equity Ratio plummeted 55.67% in 2022, then skyrocketed 41.72% in 2025.
  • Year by year, Equity Ratio stood at 0.34 in 2021, then tumbled by 49.96% to 0.17 in 2022, then rose by 21.18% to 0.21 in 2023, then rose by 20.04% to 0.25 in 2024, then increased by 16.8% to 0.29 in 2025.
  • Business Quant data shows Equity Ratio for FOLD at 0.29 in Q4 2025, 0.27 in Q3 2025, and 0.25 in Q2 2025.